Contribution of sleep research to the development of new antidepressants

Dialogues in Clinical Neuroscience

Volumn 7, Issue 4, 2005, Pages 305-313

  Le Bon, Olivier ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Antidepressant; Drug development; EEG; Sleep research; Treatment efficacy

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IPRINDOLE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NIALAMIDE; PARGYLINE; PAROXETINE; PHENELZINE; REBOXETINE; SERTRALINE; TIANEPTINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE; VILOXAZINE;

DEPRESSION; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; HUMAN; HYPERSOMNIA; INDUSTRIALIZATION; INSOMNIA; LATENT PERIOD; REM SLEEP; REVIEW; SLEEP DEPRIVATION; SLEEP DISORDER; SLOW WAVE SLEEP; SYMPTOMATOLOGY; THEORETICAL STUDY;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; RESEARCH; SLEEP; SLEEP DISORDERS;

EID: 30944447912     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Kupfer DJ, Foster FG. Interval between onset of sleep and rapid eye movement sleep as an indicator of depression. Lancet. 1972;2:684-686.
2. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry. 1992;49:651-668.
3. Uhde TW, Roy-Byrne P, Gillin JC, et al. The sleep of patients with panic disorder: a preliminary report. Psychiatry Res. 1984;12:251-259.
4. Reynolds CF, Shaw DH, Newton TF, Coble PA, Kupfer DJ. EEG sleep in generalized anxiety disorder: a preliminary comparison with primary depression. Psychiatry Res. 1983;8:81-89.
5. Insel TR, Gillin JC, Moore A, Mendelson WB, Loewenstein RJ, Murphy DL. The sleep of patients with obsessive-compulsive disorders. Arch Gen Psychiatry. 1982;39:1372-1377.
6. Feinberg I, Koresko RL, Heller N, Steinberg HR. Unusually high dream time in a hallucinating patient. Am J Psychiatry. 1965;121:1018-1020.
7. Vitiello MV, Bokan JA, Kukull WA, Muniz RL, Smallwood RG, Prinz PN. Rapid eye movement sleep measures of Alzheimer's type dementia patients and optimally healthy aged individuals. Biol Psychiatry. 1984;19:721-734.
8. Akiskal HS, Yerevanian BI, Davis GC, King D, Lemmi H. The nosologic status of borderline personality: clinical and polysomnographic study. Am J Psychiatry. 1985;142:192-198.
9. Stefos G, Staner L, Kerkhofs M, Hubain P, Mendlewicz J, Linkowski P. Shortened REM latency as a psychobiological marker for psychotic depression? An age-, gender-, and polarity-controlled study. Biol Psychiatry. 1998;44:1314-1320.
10. Staner L, Linkowski P, Mendlewicz J. Biological markers as classifiers for depression: a multivariate study. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18:899-914.
11. Perlis ML, Giles DE, Buysse DJ, Thase ME, Tu X, Kupfer DJ. Which depressive symptoms are related to which sleep electroencephalographic variables? Biol Psychiatry. 1997;42:904-913.
12. Brunello N, Armitage R, Feinberg I, et al. Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment. Biol Psychiatry. 2000;42:107-119.
13. Jindal RD, Thase ME. Treatment of insomnia associated with clinical depression. Sleep Med Rev. 2004;8:19-30.
14. Thase ME, Kupfer DJ. Current status of EEG sleep in the assessment and treatment of depression. In: Burrows GD, Werry JS, eds. Advances in Human Psychopharmacology. Vol 4. Greenwich, Conn: JAI press; 1987:93-148.
15. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989;162:1479-1484.
16. Gillin JC. Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand. 1998;98(suppl 393):39-43.
17. Benca RM, Okawa M, Uchiyama M, et al. Sleep and mood disorders. Sleep Med Rev. 1997;1:45-56.
18. Akindele MO, Evans JI, Oswald I. Monoamine oxidase inhibitors, sleep and mood. Electroencephalogr Clin Neurophysiol. 1970;29:47-56.
19. Kupfer DJ, Bowers MB. REM sleep and monoamine oxidase inhibition. Psychopharmacology. 1972;27:183-190.
20. Monti JM. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients. Br J Psychiatry. 1989;155:61-65.
21. Minot R, Luthringer R, Macher JP. Effect of moclobemide on the psychophysiology of sleep/wake cycle cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide. Int J Clin Psychopharmacol. 1993;7:181-189.
22. Dunleavy DL, Brezinova V, Oswald I, Maclean AW, Tinker M. Changes during weeks in effect of tricyclic drugs on the human sleeping brain. Br J Psychiatry. 1972;120:663-672.
23. Lacey JH, Crisp AH, Crutchfield M, Hawkins C, Hartmann M. Clomipramine and sleep: a preliminary communication. Postgrad Med J. 1977;53(suppl 4):40-45.
24. Wallach MB, Winters WD, Mandell AJ, Spooner CE. A neuropharmacological comparison of some antidepressant agents. Proc Western Pharmacol Soc. 1968;11:61-65.
25. Zung WW. Evaluating treatment methods for depressive disorders. Am J Psychiatry. 1968;124(suppl):40-48.
26. Lowy FH, Cleghorn JM, McClure DS. Sleep patterns in depression. J Nerv Mental Dis. 1971;153:10-26.
27. Shipley JE, Kupfer DJ, Dealy RS, et al. Differential effects of amitrityline and of zimelidine on the sleep electroencephalogram of depressed patients. Clin Pharmacol Ther. 1984;36:251-259.
28. Wiegand M, Berger M, Zulley J, von Zerssen D. The effect of trimipramine on sleep of patients with major depressive disorder. Pharmacopsychiatry. 1986;19:198-199.
29. Baxter BL, Gluckman MI. Iprindole: an antidepressant which does not block REM sleep. Nature. 1969;223:750-752.
30. Brezinova V, Adam K, Chapman K. Viloxazine, sleep and subjective feelings. Psychopharmacology. 1977;55:121-128.
31. Passouant P, Cadilhac J, Billiard M. Withdrawal of the paradoxical sleep by the clomipramine, electrophysiological, histochemical and biochemical study. Int J Neurol. 1975;10:186-197.
32. Kupfer DJ, Perel JM, Pollock BG, et al. Fluvoxamine versus desipramine: comparative polysomnographic effects. Biol Psychiatry. 1991;29:23-40.
33. Polc P, Haefely W, Schneeberger J. Effects of tricyclic and tetracyclic antidepressants on the sleep-wakefulness cycle of rats. In: Koella WP, Levin P, eds. Sleep, 1976, Proceedings of the European Congress on Sleep Research, Montpellier. Basel, Switzerland: Karger; 1977:380-382.
34. Tormey WP, Buckley MP, O'Kelly DA, Conboy J, Pinder RM, Darragh A. Sleep endocrine profile of the antidepressant mianserin. Curr Med Opin. 1980;6:456-460.
35. Mendlewicz J, Dunbar GC, Hoffmann G. Changes in sleep EEG architecture during treatment of depressed patients with mianserin. Acta Psychiatr Scand Suppl. 1985;320:26-29.
36. Nicholson AN, Pascoe PA. 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man. Neuropharmacology. 1986;10:1079-1083.
37. Staner L, Kerkhofs M, Detroux D, Leyman S, Linkowski P, mendlewicz J. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep. 1995;18:470-477.
38. Sharpley AL, Williamson DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ. The effects of paroxetine and nefazodone on sleep: a placebo-controlled trial. Psychopharmacology. 1996;126:50-54.
39. Rush AJ, Armitage R, Gillin JC, et al. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry. 1998;44:3-14.
40. Armitage R, Yonkers K, Cole D, Rush AJ. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed patients. J Clin Psychopharmacol. 1997;17:161-168.
41. Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ. A comparison of nefazodone and fluoxetine on mood and an objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. J Clin Psychiatry. 1997;58:185-192.
42. Winokur A, Sewitch DE, Bimaur IV, Philips JL. Effects of sertraline on sleep architecture in patients with major depression. Clin Neuropharmacol. 1992;(suppl):84B.
43. Van Bemmel AL, Beersma DGM, Van den Hoofdakker RH. Changes in EEG power density of NREM sleep in depressed patients during treatment with citalopram. J Sleep Res. 1993;2:156-162.
44. Montgomery I, Oswald I, Morgan K, Adam K. Trazodone enhances sleep in subjective quality but not in objective duration. Br J Pharmacol. 1983;16:139-144.
45. Mouret J, Lemoine P, Minuit MP, Benkelfat C, Renardet M. Effects of trazodone on the sleep of depressed subjects - a polygraphic study. Psychopharmacology. 1988;95(suppl):S37-S43.
46. Van Bemmel AL, Havermans RB, Van Diest R. Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology. 1992;107:569-574.
47. Salin-Pascual RJ, Galicia-Polo L, Drucker-Colin R. Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers. J Clin Psychiatry. 1997;58:348-350.
48. Roth T. Diagnosis and treatment of sleep disorders in the depressed elderly. Presented at: the 150th American Psychiatric Association Convention. San Diego, Calif. 1997. Abstract.
49. Luthringer R, Toussaint M, Schaltenbrand N, et al. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharmacol Bull. 1996;32:637-646.
50. Ruigt GS, Kemp B, Groenhout CM, Kamphuisen HA. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol. 1990;38:551-554.
51. Winokur A, Sateia MJ, Hayes JB, Bayles-Dazet W, MacDonald MM, Gary KA. Effects of mirtazapine on sleep architecture in patients with major depression: a pilot study. Biol Psychiatry. 1998;43:106S.
52. Macher JP, Luthringer R, Toussaint M. Brain mapping and psychoactive drugs. In: Hindmarch I, Stonier PD, eds. Human Psychopharmacology: Methods and Measures. Vol 3. New York, NY: Wiley & Sons; 1990:1-20.
53. Staner L, Mendlewicz J. Effect of a single dose of tianeptine in healthy volunteers on sleep electrophysiological parameters. Eur Psychiatry. 1994;9:141.
54. Macher JP, Minot R, Duval F, Luthringer R, Toussaint M, Schaltenbrand N. Neuroelectrophysiologic studies in abstinent and depressed alcoholics patients treated with tianeptine. Presse Med. 1991;20:1853-1857.
55. Poirier MF, Galinowski A, Amdo-Boccara I, et al. Effects of tianeptine on attention, memory and psychomotor performance using neuropsychological methods in young healthy volunteers. Eur Psychiatry. 1993;8(supple 2):95S-102S.
56. Rush AJ, Giles DE, Jarrett RB, et al. Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol Psychiatry. 1989;26:61-72.
57. Luthringer R, Minot R, Toussaint M, Calvi-Gries F, Schaltenbrand N, Macher JP. All-night EEG spectral analysis as a tool for the prediction of clinical response to antidepressant treatment. Biol Psychiatry. 1995;38:98-104.
58. Buysse DJ, Hall M, Begley A, et al. Sleep and treatment response in depression: new findings using spectral analysis. Psychiatry Res. 2001;103:51-67.
59. Kupfer DJ, Foster FG, Reich L, Thompson KS, Weiss B. EEG sleep changes as predictors in depression. Am J Psychiatry. 1976;133:622-626.
60. Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH. Sleep and treatment prediction in endogenous depression. Am J Psychiatry. 1981;138:429-434.
61. Gillin JC, Wyatt RJ, Fram D, Synder F. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology (Berl). 1978;59:267-272.
62. Höchli D, Riemann D, Zulley J, Berger M. Initial REMS suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder. Biol Psychiatry. 1986;21:1217-1220.
63. Borbély AA, Wirz-Justice A. Sleep, sleep deprivation and depression. Hum Neurobiol. 1982;1:205-210.
64. Borbély AA. A two-process model of sleep regulation. Hum Neurobiol. 1982;1:195-204.
65. Van Bemmel AL. The link between sleep and depression: the effects of antidepressants on EEG sleep. J Psychosomatic Res. 1996;42;6:555-564.
66. Vogel GW, Buffenstein A, Minter K, Hennessey A. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev. 1990;14:49-63.
67. Buysse D, ed. Sleep Disorders and Psychiatry. Review of Psychiatry. Volume 24. Washington, DC: American Psychiatric Association; 2005.